<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04919421</url>
  </required_header>
  <id_info>
    <org_study_id>RiyadhEU</org_study_id>
    <nct_id>NCT04919421</nct_id>
  </id_info>
  <brief_title>Comparison Between the Analgesic Effectiveness of Virtual Reality and Topical Anesthesia: A Clinical Study</brief_title>
  <official_title>Comparative Evaluation of The Analgesic Effect of Virtual Reality With Topical Anesthesia to Reduce Pain During Administration of Local Anesthesia</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Riyadh Elm University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Riyadh Elm University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>Yes</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      A split-mouth, controlled trial aimed to clinically compare and evaluate the effectiveness of&#xD;
      virtual reality versus topical anesthesia gel prior to administration of dental anesthesia&#xD;
      injection in reducing the perceived pain and anxiety level in adult patients and to find out&#xD;
      their preferred procedure.&#xD;
&#xD;
      Heart rate before and after the end of the procedure will be identified, pain intensity of&#xD;
      the injection will be identified using a scale, and finally patients' preference will be&#xD;
      identified using a questionnaire.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Steps of the Experiment&#xD;
&#xD;
      Step I: before the administration of the local anesthesia injection, heart rate will be&#xD;
      measured for the patients using an FDA Approved pulse oximeter (Santa Medical SM-165 Finger&#xD;
      Pulse Oximeter). Findings will be recorded.&#xD;
&#xD;
      Step II: at the first appointment, patients will be randomly allocated to receive the&#xD;
      injection of the local anesthesia either with topical anesthetic gel or with virtual reality&#xD;
      in one side of the jaw.&#xD;
&#xD;
      Step III: immediately after dental anesthesia injection procedure, the patient will be asked&#xD;
      to rate the level of perceived pain, using Wong-Baker faces pain rating scale (WBFPS).&#xD;
&#xD;
      Step IV: after the administration of the local anesthesia injection, heart rate will be&#xD;
      measured for the patients an FDA Approved pulse oximeter (Santa Medical SM-165 Finger Pulse&#xD;
      Oximeter). Findings will be recorded.&#xD;
&#xD;
      Step V: in the next appointment, the other technique (virtual reality or topical anesthetic&#xD;
      gel) will be used on the contralateral side for the same patients.&#xD;
&#xD;
      So each patient will receive local anesthesia injection twice, one with topical anesthetic&#xD;
      gel and one else with VR in the contralateral side.&#xD;
&#xD;
      Step VI: after completion of both procedures, each patient will be asked to state his/her&#xD;
      preference for the delivery system of future injections to be recorded.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">November 10, 2019</start_date>
  <completion_date type="Actual">January 30, 2020</completion_date>
  <primary_completion_date type="Actual">December 30, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Heart rate</measure>
    <time_frame>immediately after the intervention/procedure (injection)</time_frame>
    <description>heart rate will be measured for the participants using an FDA Approved pulse oximeter (Santa Medical SM-165 Finger Pulse Oximeter)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Wong-Baker faces pain rating scale (WBFPS)</measure>
    <time_frame>3 minutes after the intervention/procedure (injection)</time_frame>
    <description>A tool to measure the intensity of pain comprising a scale from 0 to 10. The patient will select a number based on the intensity of the pain, &quot;0&quot; means no pain, &quot;10&quot; means extremely severe pain.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Participant's future preference</measure>
    <time_frame>5 minutes after the intervention/procedure (injection)</time_frame>
    <description>Each participant will be asked by a questionnaire to state his/her preference for the delivery system of future injections</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">20</enrollment>
  <condition>Pain</condition>
  <arm_group>
    <arm_group_label>Virtual reality</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Participants will wear a virtual reality headset during the dental injection in which a video is playing.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Topical gel</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Participants will receive application of topical anesthetic gel on the site of dental injection.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Dental injection and topical gel application</intervention_name>
    <description>Topical anesthesia gel will be applied followed by dental injection with 1.8 ml Xylocaine 20mg/ml (DENSPLY Pharmaceutical); adrenaline: 1 : 100.000, delivered in cartridges using a 27 -gauge short needle (0.4 x 25 mm,C-K jet) and sterile non-aspirating syringe.</description>
    <arm_group_label>Topical gel</arm_group_label>
    <other_name>No other name</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Dental injection and virtual reality device</intervention_name>
    <description>Dental injection will be made while the participants are wearing virtual reality device.</description>
    <arm_group_label>Virtual reality</arm_group_label>
    <other_name>No other name</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  American Society of Anesthesiologists (ASA) class I, aged between 18 and 65, both male&#xD;
             and female, who required bilateral local anesthetic injections in the premolar teeth&#xD;
             in the upper jaw.&#xD;
&#xD;
          -  Participants are in good general health, take no medications, and have no&#xD;
             contraindications to the use of local anesthetic.&#xD;
&#xD;
          -  The ability to understand oral and written instructions, and the ability to use the VR&#xD;
             controller.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patients who need intravenous sedation cannot participate in the study.&#xD;
&#xD;
          -  If a patient requires only single visit/ treatment or if he/she cannot attend the&#xD;
             other visit.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ammar AbuMostafa, BDS, MSC</last_name>
    <role>Study Director</role>
    <affiliation>Riyadh Elm University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Riyadh Elm University</name>
      <address>
        <city>Riyadh</city>
        <country>Saudi Arabia</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Saudi Arabia</country>
  </location_countries>
  <verification_date>June 2021</verification_date>
  <study_first_submitted>October 30, 2019</study_first_submitted>
  <study_first_submitted_qc>June 6, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">June 9, 2021</study_first_posted>
  <last_update_submitted>June 6, 2021</last_update_submitted>
  <last_update_submitted_qc>June 6, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">June 9, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>pain perception</keyword>
  <keyword>virtual reality</keyword>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol, Statistical Analysis Plan, and Informed Consent Form</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>Yes</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>April 28, 2021</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/21/NCT04919421/Prot_SAP_ICF_000.pdf</document_url>
    </provided_document>
  </provided_document_section>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

